LE WE PMID CA
Psoriasis3016Psoriasis

Adalimumab ttTNFalpha

Aids

Alefacept

Arthritis (rheumatoid)

Asthma (BASKET)

Atopic dermatitis

c Jun

Cardiovascular risk

Efalizumab ttLFA1

Hand and wrist (MRT)

Infliximab ttTNFalpha

Interleukin22 IL TIF

Interleukin23

Interleukin24 MDA7

Joint (MRT)

Keratinocyte

NK cells

Psoriasis

Receptor (Catecholamines beta)

STAT6

T cell (Th17)

T cell (Th2)

Tocilizumab ttIL6

Ustekinumab ttIL12 ttIL23

2006  
1
Psoriasis and its management.
[16916825] BMJ 333(7564): 380-4 (2006)
1986  
2
1974  
3
Diseases of the skin. Psoriasis.
[4592992] Br Med J 1(5896): 27-9 (1974)
2005  
4
Topical therapies for psoriasis: evidence-based review.
[15856971] Can Fam Physician 51(): 519-25 (2005)
2009  
5
Psoriasis--new insights into pathogenesis and treatment.
[19564982] Dtsch Arztebl Int 106(1-2): 11-8, quiz 19 (2009)
2009  
6
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.
[19707417] Biologics 3(-): 303-18 (2009)
2007  
7
Efalizumab in the treatment of psoriasis.
[19707339] Biologics 1(3): 301-9 (2007)
2010  
8
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.
[20635831] J Manag Care Pharm 16(6): 402-16 (2010)
2004  
9
Advancements in the treatment of psoriasis: role of biologic agents.
[15298530] J Manag Care Pharm 10(4): 318-25 (2004)
2010  
10
Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.
[20421912] Ther Clin Risk Manag 6(-): 123-41 (2010)
2006  
11
Infliximab (Remicade) in the treatment of psoriatic arthritis.
[18360651] Ther Clin Risk Manag 2(4): 389-400 (2006)
2009  
12
Adalimumab for the treatment of psoriasis.
[19804689] Health Technol Assess 13 Suppl 2(): 49-54 (2009)
2006  
13
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
[17083854] Health Technol Assess 10(46): 1-233, i-iv (2006)
2006  
14
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
[16948890] Health Technol Assess 10(31): iii-iv, xiii-xvi, 1-239 (2006)
2000  
15
A systematic review of treatments for severe psoriasis.
[11207450] Health Technol Assess 4(40): 1-125 (2000)
2010  
16
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis.
[20694136] Core Evid 5(-): 11-22 (2010)
2007  
17
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).
[17497162] Arch Dermatol Res 299(3): 111-38 (2007)
2004  
18
Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.
[14965795] Eur J Dermatol 14(1): 41-5 (2004)
2010  
19
Systemic combination treatment for psoriasis: a review.
[20574597] Acta Derm Venereol 90(4): 341-9 (2010)
2002  
20
Trends and developments in the pharmacological treatment of psoriasis.
[12575844] Acta Derm Venereol 82(6): 401-10 (2002)
2008  
21
T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis.
[18408745] J Invest Dermatol 128(5): 1064-7 (2008)
2007  
22
2007  
23
Follow-up analysis of PSORS9 in 151 Chinese families confirmed the linkage to 4q31-32 and refined the evidence to the families of early-onset psoriasis.
[17139270] J Invest Dermatol 127(2): 312-8 (2007)
1999  
24
Animal models of psoriasis - what can we learn from them?
[10201521] J Invest Dermatol 112(4): 405-10 (1999)
2004  
25
Immunopathogenic mechanisms in psoriasis.
[14678257] Clin Exp Immunol 135(1): 1-8 (2004)
2002  
26
2009  
27
Treatment recommendations for psoriatic arthritis.
[18952643] Ann Rheum Dis 68(9): 1387-94 (2009)
2006  
28
Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?
[17038466] Ann Rheum Dis 65 Suppl 3(-): iii22-4 (2006)
2005  
29
Psoriatic arthritis imaging: a review of scoring methods.
[15708940] Ann Rheum Dis 64 Suppl 2(): ii61-4 (2005)
2005  
30
Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis.
[15708939] Ann Rheum Dis 64 Suppl 2(-): ii58-60 (2005)
2005  
31
2005  
32
Psoriatic arthritis assessment tools in clinical trials.
[15708937] Ann Rheum Dis 64 Suppl 2(-): ii49-54 (2005)
2005  
33
Psoriasis pathophysiology: current concepts of pathogenesis.
[15708932] Ann Rheum Dis 64 Suppl 2(-): ii30-6 (2005)
2005  
34
Classification and diagnostic criteria for psoriatic arthritis.
[15708931] Ann Rheum Dis 64 Suppl 2(): ii3-8 (2005)
2005  
35
Immunopathology of psoriasis and psoriatic arthritis.
[15708930] Ann Rheum Dis 64 Suppl 2(-): ii26-9 (2005)
2005  
36
Psoriasis: epidemiology, clinical features, and quality of life.
[15708928] Ann Rheum Dis 64 Suppl 2(-): ii18-23; discussion ii24-5 (2005)
2005  
37
Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
[15708927] Ann Rheum Dis 64 Suppl 2(-): ii14-7 (2005)
2005  
38
Psoriasis treatment: current and emerging directed therapies.
[15708946] Ann Rheum Dis 64 Suppl 2(-): ii87-90; discussion ii91-2 (2005)
2005  
39
Psoriasis treatment: traditional therapy.
[15708945] Ann Rheum Dis 64 Suppl 2(-): ii83-6 (2005)
2005  
40
Psoriatic arthritis treatment: biological response modifiers.
[15708944] Ann Rheum Dis 64 Suppl 2(): ii78-82 (2005)
2005  
41
Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
[15708943] Ann Rheum Dis 64 Suppl 2(-): ii74-7 (2005)
2005  
42
1976  
43
Psoriatic arthritis. Follow-up study.
[984900] Ann Rheum Dis 35(3): 206-12 (1976)
2009  
44
Psoriatic arthritis: from pathogenesis to therapy.
[19232079] Arthritis Res Ther 11(1): 214 (2009)
2006  
45
Magnetic resonance imaging in psoriatic arthritis: a review of the literature.
[16569257] Arthritis Res Ther 8(2): 207 (2006)
2002  
46
Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
[12221673] Am J Hematol 71(1): 41-4 (2002)
2007  
47
Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
[17393414] Arthritis Rheum 56(4): 1051-66 (2007)
2004  
48
Assessment of patients with psoriatic arthritis: a review of currently available measures.
[14730596] Arthritis Rheum 50(1): 24-35 (2004)
2004  
49
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.
[15199399] J Clin Invest 113(12): 1664-75 (2004)
2007  
50
Psoriatic arthritis as a distinct disease entity.
[17244977] J Postgrad Med 53(1): 63-71 (2007)
2009  
51
New insights into the pathogenesis and genetics of psoriatic arthritis.
[19182814] Nat Clin Pract Rheumatol 5(2): 83-91 (2009)
2003  
52
Current concepts and new developments in the treatment of psoriatic arthritis.
[12810935] Rheumatology (Oxford) 42(10): 1138-48 (2003)
2004  
53
Psoriasis and the new biologic agents: interrupting a T-AP dance.
[15210644] CMAJ 170(13): 1933-41 (2004)
2009  
54
Progress in understanding the immunopathogenesis of psoriasis.
[20096156] Actas Dermosifiliogr 100 Suppl 2(-): 2-13 (2009)
2008  
55
Update on the natural history and systemic treatment of psoriasis.
[19256309] Adv Dermatol 24(-): 171-96 (2008)
2011  
56
Genital psoriasis: A systematic literature review on this hidden skin disease.
[20927490] Acta Derm Venereol 91(1): 5-11 (2011)
2010  
57
MRI findings in psoriatic arthritis of the hands.
[20966327] AJR Am J Roentgenol 195(5): 1187-93 (2010)
2010  
58
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.
[19815494] Ann Rheum Dis 69(2): 394-9 (2010)
2007  
59
Psoriasis--pathophysiology, conventional, and alternative approaches to treatment.
[18069901] Altern Med Rev 12(4): 319-30 (2007)
2002  
60
Clinical features of psoriatic arthritis.
[11990861] Am J Manag Care 8(6 Suppl): S160-70 (2002)
2002  
61
Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.
[11990862] Am J Manag Care 8(6 Suppl): S171-80 (2002)
2006  
62
2010  
63
Psoriatic arthritis - update on pathophysiology, assessment, and management.
[20969551] Bull NYU Hosp Jt Dis 68(3): 191-8 (2010)
2011  
64
2005  
65
Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
[15695305] Rheumatology (Oxford) 44(3): 390-7 (2005)
2007  
66
Psoriasis: advances in pathophysiology and management.
[17989268] Postgrad Med J 83(985): 690-7 (2007)
2005  
67
2011  
68
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
[21333232] Health Technol Assess 15(10): i-xxi, 1-329 (2011)
2009  
69
Ustekinumab for the treatment of moderate to severe psoriasis.
[19846031] Health Technol Assess 13 Suppl 3(-): 61-6 (2009)
2009  
70
2010  
71
2002  
72
Pharmacological interventions for psoriatic arthritis: present and future.
[17656934] Indian J Dermatol Venereol Leprol 68(4): 187-97 (2002)
2010  
73
Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
[21079304] Indian J Dermatol Venereol Leprol 76(6): 612-21 (2010)
2010  
74
Psoriasis: what is new in nonbiologic systemic therapy in the era of biologics?
[21079305] Indian J Dermatol Venereol Leprol 76(6): 622-33 (2010)
2010  
75
Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.
[21079306] Indian J Dermatol Venereol Leprol 76(6): 634-44 (2010)
2010  
76
2011  
77
Current effective topical therapies in the management of psoriasis.
[21293834] Skin Therapy Lett 16(1): 4-7 (2011)
2010  
78
Alefacept treatment for chronic plaque psoriasis.
[20361167] Skin Therapy Lett 15(4): 1-3 (2010)
2005  
79
New developments in topical sequential therapy for psoriasis.
[16292458] Skin Therapy Lett 10(9): 1-4 (2005)
2008  
80
Psoriasis as the marker of underlying systemic disease.
[18357363] Skin Therapy Lett 13(1): 1-5 (2008)
2008  
81
Topical therapy for the management of childhood psoriasis: part I.
[18506356] Skin Therapy Lett 13(3): 1-3 (2008)
2008  
82
The role of the dermatologist in identification and treatment of the early stages of psoriatic arthritis.
[18648715] Skin Therapy Lett 13(4): 4-7 (2008)
2011  
83
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis.
[21461353] Clin Dev Immunol 2011(-): 390726 (2011)
2010  
84
Post-genomics and skin inflammation.
[20886018] Mediators Inflamm 2010(-): - (2010)
2010  
85
Lipid disturbances in psoriasis: an update.
[20706605] Mediators Inflamm 2010(-): - (2010)
2008  
86
The challenge of early diagnosis of psoriatic arthritis.
[18176985] J Rheumatol 35(1): 3-5 (2008)
2012  
87
Molecular Mechanisms Governing IL-24 Gene Expression.
[22536164] Immune Netw 12(1): 1-7 (2012)
2011  
88
Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression.
[21357535] J Immunol 186(7): 4098-109 (2011)
2008  
89
2011  
90
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.
[21267358] Drug Des Devel Ther 5(-): 41-9 (2011)
2008  
91
Review paper: preclinical models of psoriasis.
[18587106] Vet Pathol 45(4): 563-75 (2008)
2010  
92
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
[20445552] J Invest Dermatol 130(7): 1785-96 (2010)
2010  
93
Molecular dissection of psoriasis: integrating genetics and biology.
[19812592] J Invest Dermatol 130(5): 1213-26 (2010)
2010  
94
A role for TGFbeta signaling in the pathogenesis of psoriasis.
[19710682] J Invest Dermatol 130(2): 371-7 (2010)
2009  
95
The IL-23/Th17 axis in the immunopathogenesis of psoriasis.
[19322214] J Invest Dermatol 129(6): 1339-50 (2009)
2011  
96
Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.
[21503693] Curr Rheumatol Rep 13(4): 353-9 (2011)
2008  
97
Altered bone remodeling in psoriatic arthritis.
[18662512] Curr Rheumatol Rep 10(4): 311-7 (2008)
2007  
98
Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.
[18177599] Curr Rheumatol Rep 9(6): 461-7 (2007)
2007  
99
Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles.
[17498423] Dermatol Online J 13(2): 4 (2007)
2011  
100
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis.
[21386955] J Clin Aesthet Dermatol 4(2): 28-39 (2011)
2011  
101
Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?
[22110777] Dermatoendocrinol 3(3): 180-6 (2011)
2007  
102
Skin diseases with high public health impact. Psoriasis.
[17951158] Eur J Dermatol 17(6): 563-4 (2007)
2007  
103
Clinical assessment in psoriatic arthritis.
[17828349] Reumatismo 59 Suppl 1(-): 68-72 (2007)
2007  
104
Conventional therapy of psoriatic arthritis: evidence-based review.
[17828352] Reumatismo 59 Suppl 1(-): 81-4 (2007)
2009  
105
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab.
[21436972] Clin Cosmet Investig Dermatol 2(-): 95-103 (2009)
2009  
106
Biologics in the management of psoriasis.
[21436974] Clin Cosmet Investig Dermatol 2(-): 111-28 (2009)
2011  
107
Definition of treatment goals for moderate to severe psoriasis: a European consensus.
[20857129] Arch Dermatol Res 303(1): 1-10 (2011)
2007  
108
The role of dendritic cells in the immunopathogenesis of psoriasis.
[17680257] Arch Dermatol Res 299(8): 359-66 (2007)
2006  
109
The long-term efficacy and safety of new biological therapies for psoriasis.
[16691429] Arch Dermatol Res 298(1): 7-15 (2006)
2007  
110
Beta adrenergic receptors in keratinocytes.
[17903623] Dermatol Clin 25(4): 643-53, x (2007)
2008  
111
Novel immunobiologics for psoriasis.
[20040934] Indian J Pharmacol 40(3): 95-102 (2008)
2010  
112
New insights in the immunologic basis of psoriasis.
[20430301] Semin Cutan Med Surg 29(1): 3-9 (2010)
2007  
113
The new psoriasis pathway: toward a unified theory of immunopathogenesis.
[20477148] Expert Rev Clin Immunol 3(4): 447-50 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Therapie der Psoriasis vulgaris
  • Psoriasis des behaarten Kopfes
  • Therapie mit Methotrexat in der Dermatologie


  • Search PubMed and many other databases on the combined search terms

    GG: psoriasis

  • Psoriasis

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia